Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
03/20/2017 03/21/2017 03/22/2017 03/23/2017 03/24/2017 Date
103.75(c) 101.65(c) 101.55(c) 102.15(c) 103.85 Last
215 060 419 184 408 378 307 943 732 760 Volume
-0.19% -2.02% -0.10% +0.59% +1.66% Change
More quotes
Financials (€)
Sales 2017 15 592 M
EBIT 2017 3 260 M
Net income 2017 1 846 M
Debt 2017 9 565 M
Yield 2017 1,25%
Sales 2018 16 042 M
EBIT 2018 3 551 M
Net income 2018 2 074 M
Debt 2018 7 461 M
Yield 2018 1,35%
P/E ratio 2017 23,69
P/E ratio 2018 20,10
EV / Sales2017 1,46x
EV / Sales2018 1,29x
Capitalization 13 202 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.It operates through the following segments: Healthcare, Life Science, and Performance Materials.The Healthcare segment comprises of the businesses that were reported separately as the Merck Serono and Consumer Health... 
Sector
Pharmaceuticals
Calendar
04/28Shareholder meeting
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
02:02p MERCK : Global Analyzer for Particle Counters Market- HCT Instruments, Honri, IQ..
03/23 MERCK : FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Ap..
03/23 PFIZER : FDA Grants Approval for BAVENCIO (avelumab), the First Immunotherapy Ap..
03/23 PFIZER : FDA Grants Approval for BAVENCIO (avelumab)
03/22 “BOLD & VIBRANT” : Merck KGaA, Darmstadt, Germany, Presents Innovati..
03/22 MERCK : unveils 2017 Darmstadt and Nairobi accelerator startups
03/21 MERCK : Introduces Mobius MyWay Portfolio for Customized Single-Use Assemblies
03/18 German shares closes flat Tuesday
03/16 MERCK : Global Trimethylgallium (TMG) Market- Akzo Nobel, SAFC Hitech, Albemarle..
03/16 MERCK : American Cancer Society Celebrates Young Scholars Joining All of Me Proj..
More news
Sector news : Specialty & Advanced Pharmaceuticals
03:42p NOVO NORDISK A/S : EMA panel backs Novo Nordisk's haemophilia B drug
03:14a YouTube's bid to grab TV dollars imperiled by advertiser revolt
03/23DJPRESS RELEASE : FDA Grants Approval for -3-
03/23DJPRESS RELEASE : FDA Grants Approval for -2-
03/23DJPRESS RELEASE : FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immuno..
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2016Towards the breakout of a major resistance level
2014Prices move higher as positive news are released
More Strategies
Latest Tweets
05:47p~ @pfizer , @Merck KGaA score watershed FDA nod on #cancer immunotherapy Bave.. 
03:53pFDA approves Pfizer, German Merck immunotherapy for skin cancer: Yahoo/Reuter.. 
03:19pThat $95M Merck gamble to acquire cCAM? It didn’t pay off.: Endpoints  
03:16pMerck KGaA given €110.00 PT by Independent Research GmbH. neutral rating.  
02:56pEMA???s Recommends Approval Of Merck & Co.???s KEYTRUDA (Pembrolizumab) F.. 
More tweets
Qtime:101
News from SeekingAlpha
03/23 FDA OKs Merck KGaA and Pfizer's avelumab for rare type of skin cancer
03/23 BeiGene, Another Beijing Venture In Cancer Therapy
03/10 Pfizer And Merck Go For An Even Longer Throw Of The Javelin
03/09 Merck KGaA's (MKGAF) CEO Stefan Oschmann on Q4 2016 Results - Earnings Call T..
03/09 Merck KGaA 2016 Q4 - Results - Earnings Call Slides
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 110 €
Spread / Average Target 7,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA3.03%14 210
ABBVIE INC4.84%104 618
KYOWA HAKKO KIRIN CO L..5.62%8 847
JAZZ PHARMACEUTICALS P..30.70%8 513
CONVATEC GROUP PLC12.87%6 431
MALLINCKRODT PLC-13.33%4 521
More Results